Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020
Year: 2022
Type: review
Study design: Systematic Review
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.30106
Institutions: University of Massachusetts Chan Medical School, Boston Children's Hospital, Harvard University, Children's Hospital of Philadelphia, University of Pennsylvania Health System, University of Pennsylvania, Vall d'Hebron Hospital Universitari, Institute of Cancer Research, Royal Marsden Hospital, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310603786
